$27.97
-4.32 (-13.38%)
Open$31.10
Previous Close$32.29
Day High$31.68
Day Low$27.82
52W High$34.39
52W Low$4.60
Volume—
Avg Volume8.05M
Market Cap4.55B
P/E Ratio—
EPS$-0.83
SectorBiotechnology
Analyst Ratings
Strong Buy
18 analysts
Price Target
+1.0% upside
Current
$27.97
$27.97
Target
$28.24
$28.24
$22.54
$28.24 avg
$42.65
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 79.04M | 58.16M | 421.41M |
| Net Income | -128,728,625 | -85,257,018 | -114,600,480 |
| Profit Margin | -162.9% | -154.7% | -27.2% |
| EBITDA | -138,119,074 | -96,558,334 | -127,773,532 |
| Free Cash Flow | — | — | -89,915,808 |
| Rev Growth | +35.9% | +35.9% | +7.1% |
| Debt/Equity | — | — | 0.61 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |